Priyadharsini Nagarajan, MD PhD MBBS FCAP FASCP

Peer-Reviewed Articles

1. Bartley BR, Huen A, Rady PL, Tyring SK, Nagarajan P, Aung PP, Curry JL, Ivan D, Torres-Cabala CA, Prieto VG, Cho WC. Eosinophilic homogeneous intracytoplasmic inclusion bodies: Unique viral cytopathic changes associated with epidermodysplasia verruciformis and human papillomavirus type 49. J Cutan Pathol 49(7), 2022. e-Pub 2022. PMID: 35262953.
2. Seervai RNH, Heberton M, Cho WC, Gill P, Murphy MB, Aung PP, Nagarajan P, Torres-Cabala CA, Patel AB, Ruiz-Bañobre J, Om A, Yamamoto T, Nikolaou V, Curry JL. Severe de novo pustular psoriasiform immune-related adverse event associated with nivolumab treatment for metastatic esophageal adenocarcinoma. J Cutan Pathol 49(5):472-481, 2022. e-Pub 2021. PMID: 34888886.
3. Farah M, Milton DR, Gross ND, Nagarajan P, Gu J, Curry JL, Ivan D, Torres-Cabala CA, Myers JN, Prieto VG, Aung PP. Histopathologic Features Predictive of Metastasis and Survival in 230 Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck and Non-Head and Neck Locations: A Single-Center Retrospective Study. J Eur Acad Dermatol Venereol. e-Pub 2022. PMID: 35426183.
4. Cho WC, Gill P, Nagarajan P, Aung PP, Torres-Cabala CA, Curry JL, Ivan D, Lester L, Prieto VG. Cutaneous Lymphoid Hyperplasia With T-Cell Clonality and Monotypic Plasma Cells Secondary to a Tick Bite: A Hidden Critter and the Power of Deeper Levels. Am J Dermatopathol 44(3):226-229, 2022. PMID: 35050559.
5. Mitra D, Rao PK, Nagarajan P, Bishop AJ, Farooqi AS, Gershenwald JE, Wargo J, Keung EZ, Fisher SB, Amaria RN, Davies MA, Ross MI, Guadagnolo BA. Outcomes after sphincter-sparing local therapy for anorectal melanoma: 1989-2020. Pract Radiat Oncol. e-Pub 2022. PMID: 35278716.
6. Amit M, Liu C, Mansour J, Gleber-Netto FO, Tam S, Baruch EN, Aashiq M, El-Naggar AK, Moreno AC, Rosenthal DI, Glisson BS, Ferrarotto R, Wong MK, Tsai K, Flores ER, Migden MR, Silverman DA, Li G, Khanna A, Goepfert RP, Nagarajan P, Weber RS, Myers JN, Gross ND. Elective neck dissection versus observation in patients with head and neck cutaneous squamous cell carcinoma. Cancer 127(23):4413-4420, 2021. PMID: 34358340.
7. Goldfarb JA, Ferrarotto R, Gross N, Goepfert R, Debnam JM, Gunn B, Nagarajan P, Esmaeli B.. Immune Checkpoint Inhibitors for Treatment of Periorbital Squamous Cell Carcinoma. Br J Ophthalmol, 2021. PMID: 34625433.
8. Seervai RNH, Cho WC, Chu EY, Marques-Piubelli ML, Ledesma DA, Richards K, Heberton MM, Nelson KC, Nagarajan P, Torres-Cabal CA, Prieto VG, Curry JL. Diverse landscape of dermatologic toxicities from small-molecule inhibitor cancer therapy. Journal of Cutaneous Pathology, 2021. PMID: 34622477.
9. Cho WC, Gill P, Aung PP, Gu J, Nagarajan P, Ivan D, Curry JL, Prieto VG, Torres-Cabala CA. The utility of digital pathology in improving the diagnostic skills of pathology trainees in commonly encountered pigmented cutaneous lesions during the COVID-19 pandemic: A single academic institution experience. Annals of Diagnostic Pathology 54, 2021. PMID: 34418768.
10. Gill P, Richards K, Cho WC, Nagarajan P, Aung PP, Ivan D, Curry JL, Priieto VG, Torres-Cabala CA. Localized cutaneous argyria: Review of a rare clinical mimicker of melanocytic lesions. Annals of Diagnostic Pathology 54, 2021. PMID: 34214703.
11. Mejbel HA, Torres-Cabala CA, Milton DR, Ivan D, Nagarajan P, Curry JL, Ciurea AM, Rubin AI, Hwu WJ, Prieto VG, Aung PP. Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous Melanoma. Arch Pathol Lab Med 145(943-952), 2021. PMID: 33290520.
12. Collins K, Gu J, Aung PP, Nagarajan P, Curry JL, Huen A, Ivan D, Prieto VG, Tetzlaff MT, Duvic M, Miranda RN, Vega F, Torres-Cabala CA. Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders?. Virchows Archives 479(2):377-383, 2021. PMID: 33604757.
13. Ferrarotto R, Amit M, Nagarajan P, Rubin ML, Yuan Y, Bell D, El-Naggar A, Johnson JM, Morrison WH, Rosenthal DI, Glisson BS, Johnson FM, Lu C, Mott FE, Esmaeli B, Diaz E, Gidley PW, Goepfert RP, Lewis CM, Weber RS, Wargo JA, Basu S, Duan F, Yadav SS, Sharma P, Allison JP, Myers JN, Gross ND. Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck. Clinical Cancer Research 27(16):4557-4565, 2021. PMID: 34187851.
14. Cho WC, Wang WL, Milton DR, Ingram DR, Nagarajan P, Curry JL, Ivan D, Lazar AJ, Hwu WJ, Prieto VG, Torres-Cabala CA, Aung PP. Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentiginous Melanoma Than in Other Types of Cutaneous Melanoma. Arch Pathol Lab Med 145(7):842-850, 2021. PMID: 33053175.
15. Collins K, Nagarajan P*, Aung PP* (*Equal contributors). Distant Cutaneous Metastasis Of Malignant Epithelioid Mesothelioma. J Cutan Pathol 48(7):902-907, 2021. PMID: 33258154.
16. Gill P, Cho WC, Prieto VG, Nagarajan P. Metaplasia Mimicking Malignancy: A Challenging Case of Florid Eccrine Squamous Syringometaplasia (***Mentorship Role***). Journal of Cutaneous Pathlology 48(7):995-998, 2021. PMID: 33749861.
17. Sezen D, Patel RR, Tang C, Onstad M, Nagarajan P, Patel SP, Welsh JW, Lin LL. Immunotherapy combined with high- and low-dose radiation to all sites leads to complete clearance of disease in a patient with metastatic vaginal melanoma. Gynecologic Oncology 161(3):645-652, 2021. PMID: 33795130.
18. El-Hadad C, Rubin ML, Nagarajan P, Ford JR, Xu S, Ning J, Esmaeli B. Prognostic Factors for Orbital Exenteration, Local Recurrence, Metastasis, and Death From Disease in Conjunctival Squamous Cell Carcinoma. Ophthalmic Plast Reconstr Surg 37(3):262-268, 2021. PMID: 33009325.
19. Tam S, Gajera M, Luo X, Glisson BS, Ferrarotto R, Johnson FM, Mott FE, Gillison ML, Lu C, Le X, Blumenschein GR, Wong MK, Rosenthal DI, Nagarajan P, El-Naggar AK, Migden MR, Weber RS, Myers JN, Gross ND. Cytotoxic and targeted systemic therapy in patients with advanced cutaneous squamous cell carcinoma in the head and neck. Head Neck 43(5):1592-1603, 2021. PMID: 33522021.
20. Sweeney KJ, Tetzlaff MT, Vega F, Gillenwater A, Zuo Z, Gross N, Nagarajan P, Wargo J, Nelson K, Prieto VG, Torres-Cabala CA, Curry JL. Tertiary lymphoid structures with overlapping histopathologic features of cutaneous marginal zone lymphoma during neoadjuvant cemiplimab therapy are associated with antitumor response. Journal of Cutaneous Pathology 48(5):674-679, 2021. PMID: 33399228.
21. Wiggins CJ, Morris VK, Klimas NK, Nagarajan P, Curry JL, Richards KN. Bullous Pemphigoid secondary to Bintrafusp alfa, a bifunctional fusion protein targeting TGF-beta and PD-L1. JAAD Case Reports 13:23-25, 2021. PMID: 34136620.
22. Kwon D, Ronen S, Giubellino A, Keiser E, Aung PP, Nagarajan P, Tetzlaff MT, Ivan D, Curry JL, Prieto VG, Torres-Cabala CA. Cutaneous Adnexal Carcinosarcoma: Immunohistochemical and Molecular Evidence of Epithelial Mesenchymal Transition. J Cutan Pathol 48(4):526-534, 2021. PMID: 32564423.
23. Ronen S, Keiser E, Collins KM, Aung PP, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Prieto VG, Hymes S, Medeiros J, Torres-Cabala CA. Langerhans cell sarcoma involving skin and showing epidermotropism: a comprehensive review. Journal of Cutaneous Pathology 48(4):547-557, 2021. PMID: 32644218.
24. Guan Y, Yang YL, Nagarajan P, Ge Y. Transcriptional and signaling regulation of skin epithelial stem cells in homeostasis, wounds, and cancer. Exp Dermatol 30(4):529-545, 2021. PMID: 33249665.
25. Amit M, Liu C, Netto Gleber F, Kini S, Tam S, Benov A, Aashiq M, El-Naggar AK, Moreno AC, Rosenthal DI, Glisson BS, Ferrarotto R, Wong MK, Migden MR, Baruch E, Li G, Khanna A, Goepfert RP, Nagarajan P, Weber RS, Myers JN, Gross ND. Inclusion of Extranodal Extension in the Lymph Node Classification of Cutaneous Squamous Cell Carcinoma of the Head and Neck. Cancer 127(8):1238-1245, 2021. PMID: 33320343.
26. Chen PP, Ramalingam P, Alvarado-Cabero I, Euscher ED, Nagarajan P, Lawson BC, Malpica A. High-grade Neuroendocrine Carcinomas of the Vulva: A Clinicopathologic Study of 16 Cases. American Journal of Surgical Pathology 45(3):304-316, 2021. PMID: 32826525.
27. Mejbel HA, Torres-Cabala CA, Milton DR, Ivan D, Feldmeyer L, Namikawa K, Nagarajan P, Tetzlaff MT, Curry JL, Ross MI, Hwu WJ, Prieto VG, Aung PP. Prognostic significance of acral lentiginous histologic type in T1 melanoma. Modern Pathology 34(3):572-583, 2021. PMID: 32759976.
28. Amit M, Liu C, Netto Gleber F, Kini S, Tam S, Benov A, Aashiq M, El-Naggar AK, Moreno AC, Rosenthal DI, Glisson BS, Ferrarotto R, Wong MK, Migden MR, Li G, Khanna A, Goepfert RP, Nagarajan P, Weber RS, Myers JN, Gross ND. Integrating Depth of Invasion in T Classification Improves the Prognostic Performance of the American Joint Committee on Cancer Primary Tumor Staging System for Cutaneous Squamous Cell Carcinoma of the Head and Neck. European Journal of Cancer 144:169-177, 2021. PMID: 33352413.
29. Ronen S, Al-Rohil RN, Keiser E, Jour G, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Middleton LP, Torres-Cabala CA, Gershenwald JE, Aung PP, Prieto VG. Discordance in Diagnosis of Melanocytic Lesions and Its Impact on Clinical Management. Arch Pathol Lab Med, 2021. e-Pub 2021. PMID: 33577643.
30. McNally MA, Vangipuram R, Campbell MT, Nagarajan P, Patel AB, Curry JL, Heberton M. Paraneoplastic pemphigus manifesting in a patient treated with pembrolizumab for urothelial carcinoma. JAAD Case Rep 10:82-84, 2021. PMID: 33778141.
31. Roy M, Teshome M, Damodaran S, Sahin A, Khazai L, Arribas E, Candelaria RP, Scoggins ME, Lane DL, Giordano SH, Albarracin CT, Prieto VG, Nagarajan P. Male Mammary Paget Disease: A Tale of 2 Contrasting Cases (***Mentorship Role***). American Journal of Dermatopathology 42(12):981-985, 2020. PMID: 33289978.
32. Farah M, Reuben A, Spassova I, Yang RK, Kubat L, Nagarajan P, Ning J, Li W, Aung PP, Curry JL, Torres-Cabala CA, Hudgens CW, Ugurel S, Schadendorf D, Gumbs C, Little LD, Futreal A, Wistuba II, Prieto VG, Wang L, Wong MK, Wargo JA, Becker JC, Tetzlaff MT. T cell repertoire in combination with T cell density predicts clinical outcomes in patients with Merkel cell carcinoma. J Invest Dermatol 140(11):2146-2156, 2020. e-Pub 2020. PMID: 32304704.
33. Marques-Piubelli ML, Tetzlaff MT, Nagarajan P, Duke TC, Glitza Oliva IC, Ledesma DA, Aung PP, Torres-Cabala CA, Wistuba II, Prieto VG, Nelson KC, Curry JL. Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinoma. J Cutan Pathol 47(10):954-959, 2020. e-Pub 2020. PMID: 32394425.
34. Ramani NS, Aung PP, Gu J, Sfamenos S, Sdringola-Maranga C, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Diab A, Prieto VG, Hwu WJ, Torres-Cabala CA. TERT amplification but not activation of canonical Wnt/β-catenin pathway is involved in acral lentiginous melanoma progression to metastasis. Mod Pathol 33(10):2067-2074, 2020. e-Pub 2020. PMID: 32404956.
35. Chen PL, Neishaboori N, Tetzlaff MT, Chen WS, Aung PP, Curry JL, Nagarajan P, Ivan D, Hwu WJ, Prieto VG, Torres-Cabala CA. BAP-1 Expression Status by Immunohistochemistry in Cellular Blue Nevus and Blue Nevus-like Melanoma. American Journal of Dermatopathology 42(5):313-321, 2020. PMID: 32310893.
36. Farah M, Nelson KC, Tetzlaff MT, Nagarajan P, Torres-Cabala CA, Prieto VG, Curry JL, Aung PP. Lichen planus related to transforming growth factor beta inhibitor in a patient with metastatic chondrosarcoma: a case report. Journal of Cutaneous Pathology 47(5):490-493, 2020. e-Pub 2020. PMID: 31930527.
37. Tam S, Yao CMK, Amit M, Gajera M, Luo X, Treistman R, Khanna A, Aashiq M, Nagarajan P, Bell D, El-Naggar A, Migden M, Wong M, Glisson B, Ferrarotto R, Esmaeli B, Rosenthal D, Li G, Weber RS, Myers JN, Gross ND. Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck. JAMA Otolaryngol Head Neck Surg 146(2):128-135, 2020. PMID: 31804658.
38. Guan Y, Wang G, Fails D, Nagarajan P, Ge Y. Unraveling cancer lineage drivers in squamous cell carcinomas. Pharmacol Ther 206:107448, 2020. PMID: 31836455.
39. Mejbel HA, Nelson KC, Pradhan D, Ivan D, Tetzlaff MT, Curry JL, Nagarajan P, Torres-Cabala CA, Prieto VG, Aung PP. Cutaneous neoplasms composed of melanoma and carcinoma: A rare but important diagnostic pitfall and review of the literature. Journal of Cutaneous Pathology 47(1):36-46, 2020. PMID: 31361351.
40. Namikawa K, Aung PP, Milton D, Tetzlaff MT, Torres-Cabala CA, Curry JL, Nagarajan P, Ivan D, Ross MI, Gershenwald JE, Prieto VG. Correlation of Tumor Burden in Sentinel Lymph Nodes with Tumor Burden in Nonsentinel Lymph Nodes and Survival in Cutaneous Melanoma. Clinical Cancer Research 25(24):7585-7593, 2019. PMID: 31570567.
41. Ruiz SJ, Al Salihi S, Prieto VG, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Torres-Cabala CA, Aung PP. Unusual cutaneous metastatic carcinoma. Ann Diagn Pathol 43:151399, 2019. PMID: 31675677.
42. Pradhan D, Jour G, Milton D, Vasudevaraja V, Tetzlaff MT, Nagarajan P, Curry JL, Ivan D, Long L, Ding Y, Ezhilarasan R, Sulman EP, Diab A, Hwu WJ, Prieto VG, Torres-Cabala CA, Aung PP. Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral Melanoma. Cancers (Basel) 11(12), 2019. PMID: 31888295.
43. Tetzlaff MT, Tang S, Duke T, Cabanillas ME, Zou Z, Nagarajan P, Aung PP, Torres-Cabala CA, Duvic M, Prieto VG, Heun A, Curry JL. Lichenoid dermatitis toxicity from checkpoint inhibitor therapy: An immune-related adverse event with mycosis fungoides-like morphologic and molecular features. Journal of Cutaneous Pathology 46(11):872-877, 2019. e-Pub 2019. PMID: 31254410.
44. Yildiz P, Aung PP, Milton D, Hruska C, Ivan D, Curry JL, Nagarajan P, Torres-Cabala CA, Tetzlaff MT, Prieto VG. Measurement of Tumor Thickness in Cutaneous Squamous Cell Carcinomas: Do the Different Methods Provide Better Prognostic Data?. American Journal of Dermatopathology 46(11):872-877, 2019. e-Pub 2019. PMID: 31464719.
45. Mejbel HA, Arudra SKC, Pradhan D, Torres-Cabala CA, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Duose DY, Luthra R, Prieto VG, Ballester LY, Aung PP. Immunohistochemical and Molecular Features of Melanomas Exhibiting Intratumor and Intertumor Histomorphologic Heterogeneity. Cancers (Basel) 11(11), 2019. PMID: 31684113.
46. Sukswai N, Aung PP, Yin C, Li S, Wang W, Wang SA, Ortega V, Lyapichev K, Alfattal R, Angelova E, Tang Z, Loghavi S, Kanagal-Shamanna R, Miranda RN, Pemmaraju N, Bhalla K, Konopleva M, Nagarajan P, Medeiros LJ, Khoury JD. Dual Expression of TCF4 and CD123 is Highly Sensitive and Specific for Blastic Plasmacytoid Dendritic Cell Neoplasm. American Journal of Surgical Pathology 43(10):1429-1437, 2019. e-Pub 2019. PMID: 31261288.
47. Mauzo SH, Tetzlaff MT, Nelson K, Amaria R, Patel S, Aung PP, Nagarajan P, Torres-Cabala CA, Diab A, Prieto VG, Curry JL. Regressed melanocytic nevi secondary to pembrolizumab therapy: an emerging melanocytic dermatologic effect from immune checkpoint antibody blockade. International Journal of Dermatology 58(9):1045-1052, 2019. PMID: 29152725.
48. Nagarajan P, Piao J, Ning J, Noordenbos L, Curry JL, Torres-Cabala CA, Diwan A, Ivan D, Aung PP, Ross M, Royal R, Wargo J, Wang WL, Samdani R, Lazar AJ, Rashid A, Davies M, Prieto VG, Gershenwald J, Tetzlaff MT. Prognostic Model for Patient Survival in Primary Anorectal Mucosal Melanoma: Stage at Presentation Determines Relevance of Histopathologic Features. Modern Pathology 33(3):496-513, 2019. PMID: 31383963.
49. Saenz Ibarra B, Huen A, Nagarajan P, Torres-Cabala CA, Prieto VG, Aung PP. From Mycosis Fungoides to Herpetic Folliculitis: The Significance of Deeper H&E Tissue Sections in Dermatopathology. Journal of Cutaneous Pathlology 46(8):624-626, 2019. PMID: 30883857.
50. Sagiv O, Ding S, Ferrarotto R, Glisson B, Altan M, Johnson F, Elamin Y, Thakar SD, Nagarajan P, Esmaeli B. Impact of Food and Drug Administration Approval of Vismodegib on Prevalence of Orbital Exenteration as a Necessary Surgical Treatment for Locally Advanced Periocular Basal Cell Carcinoma. Ophthalmic Plastic and Reconstructive Surgery 35(4):350-353, 2019. e-Pub 2018. PMID: 30365473.
51. Sagiv O, Nagarajan P, Ferrarotto R, Knadl TJ, Thakar SD, Glisson B, Altan M, Esmaeli B. Ocular Preservation with Neoadjuvant Vismodegib in Patients with Locally Advanced Periocular Basal Cell Carcinoma. British Journal of Ophthalmology 103(6):775-780, 2019. e-Pub 2018. PMID: 30021814.
52. Aung PP, Parra ER, Barua S, Sui D, Ning J, Mino B, Ledesma DA, Curry JL, Nagarajan P, Torres Cabala CA, Efstathiou E, Hoang A, Wong MKK, Wargo JA, Lazar AJ, Rao A, Prieto VG, Wistuba II, Tetzlaff MT. B7-H3 expression in Merkel cell carcinoma-associated endothelial cells correlates with locally aggressive primary tumor features and increased vascular density. Clinical Cancer Research 1(25):3455-3467, 2019. e-Pub 2019. PMID: 30808776.
53. Nagarajan P, El-Hadad C, Gruschkus SK, Ning J, Hudgens CW, Sagiv O, Gross N, Tetzlaff MT, Esmaeli B. PD-L1/PD-1 Expression, Composition of Tumor-Associated Immune Infiltrate and HPV Status in Conjunctival Squamous Cell Carcinoma. Investigative Ophthalmology and Visual Sciences 60(6):2388-2398, 2019. PMID: 31141610.
54. Mauzo SH, Tetzlaff MT, Milton DR, Siroy AE, Nagarajan P, Torres-Cabala CA, Ivan D, Curry JL, Hudgens CW, Wargo JA, Sahin AA, Pettaway CA, Prieto VG, Aung PP. Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted Therapy. Cancers (Basel) 11(6), 2019. PMID: 31146499.
55. Xu S, Sagiv O, Rubin ML, Sa HS, Tetzlaff MT, Nagarajan P, Ning J, Esmaeli B. Validation Study of the AJCC Cancer Staging Manual, Eighth Edition, Staging System for Eyelid and Periocular Squamous Cell Carcinoma. JAMA Ophthalmology 137(5):537-542, 2019. PMID: 30869769.
56. Aung PP, Nagarajan P, Tetzlaff MT, Curry JL, Guilin T, Abdullaev Z, Pack SD, Ivan D, Prieto VG, Torres-Cabala CA. Melanoma with loss of BAP1 expression in patients with no family history of BAP1-associated cancer susceptibility syndrome: A case series. American Journal of Dermatopathology 41(3):167-179, 2019. e-Pub 2019. PMID: 30801340.
57. Farah M, Nagarajan P, Curry JL, Tang Z, Aung PP, Torres-Cabala, CA, Prieto VG, Wargo JA, Tetzlaff MT. Spitzoid melanoma with histopathologic features of ALK gene rearrangement exhibiting ALK copy number gain: A novel mechanism of ALK activation in Spitzoid neoplasia. British Journal of Dermatology 180(2):404-408, 2019. PMID: 29897634.
58. Konopinski JC, Danialan R, Torres-Cabala CA, Tetzlaff MT, Nagarajan P, Curry JL, Ivan D, Prieto VG, Aung PP. Melanoma coexisting with solar elastosis: a potential pitfall in the differential diagnosis between nevus and melanoma. Human Pathology 84:270-274, 2019. e-Pub 2018. PMID: 30359637.
59. Fedda F, Migden MR, Curry JL, Torres-Cabala CA, Tetzlaff MT, Aung PP, Prieto VG, Ivan D, Myers JN, Nagarajan P. Angiotropism in Recurrent Cutaneous Squamous Cell Carcinoma: Implications for Regional Tumor Recurrence and Extravascular Migratory Spread (**Mentoring role**). Journal of Cutaneous Pathology 46(2):152-158, 2019. e-Pub 2018. PMID: 30414196.
60. Ronen S, Ivan D, Torres-Cabala CA, Curry JL, Tetzlaff MT, Nagarajan P, Suster S, Prieto VG. Post-Radiation Vascular Lesions of the Breast. Journal of Cutaneous Pathology 46(1):52-58, 2019. PMID: 30251277.
61. Curry JL, Tetzlaff MT, Wang S, Landon G, Patel S, Nagarajan P, Khoury J, Loghavi S, Prieto VG, DiNardo C, Gershenwald JE. Case Report of Myeloid Sarcoma Masquerading as In-Transit Metastasis at a Previous Melanoma Site: Avoiding a Diagnostic Pitfall. American Journal of Dermatopathology 40(11):831-835, 2018. e-Pub 2018. PMID: 29863571.
62. Arudra K, Patel R, Tetzlaff MT, Hymes S, Subbiah V, Torres-Cabala CA, Aung PP, Nagarajan P, Diab A, Prieto VG, Nelson K, Curry JL. Calcinosis cutis dermatologic toxicity associated with fibroblast growth factor receptor inhibitor for the treatment of Wilms tumor. Journal of Cutaneous Pathology 45(10):786-790, 2018. e-Pub 2018. PMID: 30021048.
63. Farah M, Nagarajan P, Torres-Cabala CA, Tetzlaff MT, Curry JL, Ivan D, Prieto VG, Aung PP. Metastatic melanoma with histiocytoid cytomorphology after treatment with immunotherapy: a histologic mimic and diagnostic pitfall. Journal of Cutaneous Pathology 45(7):545-549, 2018. PMID: 29672900.
64. Trinidad C, Nelson KC, Glitza Oliva IC, Torres-Cabala CA, Nagarajan P, Tetzlaff MT, Ivan D, Hwu WJ, Prieto VG, Curry JL, Aung PP. Dermatologic Toxicity from Immune Checkpoint Blockade Therapy with an Interstitial Granulomatous Pattern. Journal of Cutaneous Pathology 45(7):504-507, 2018. e-Pub 2018. PMID: 29633300.
65. Dolkar T, Trinidad CM, Nelson K, Amaria RN, Nagarajan P, Torres-Cabala CA, Tetzlaff MT, Ivan D, Prieto VG, Curry JL, Aung PP. Dermatologic Toxicity from Novel Therapy using Antimicrobial Peptide LL-37 in Melanoma: A Detailed Examination of the Clinicopathologic Features. Journal of Cutaneous Pathology 45(7):539-544, 2018. PMID: 29665030.
66. Al-Rohil, Milton DR, Nagarajan P, Feldmeyer L, Curry JL, Torres-Cabala CA, Ivan D, Prieto VG, Tetzlaff MT, Aung PP. Intratumoral and Peritumoral Lymphovascular Invasion Detected by D2-40 Immunohistochemistry Correlates with Metastasis in Primary Cutaneous Merkel Cell Carcinoma. Human Pathology 77:98-107, 2018. PMID: 29601841.
67. Mauzo SH, Prieto VG, Torres-Cabala CA, Wang WL, Chakravarti N, Tetzlaff MT, Nagarajan P, Curry JL, Ivan D, Milton DR, Aung PP. Summary of Expression of SPARC Protein in Cutaneous Vascular Neoplasms and Mimickers. Annals of Diagnostic Pathology 34:151-154, 2018. PMID: 29660567.
68. Lewis DJ, Miranda RN, Oh CW, Hinojosa T, Medeiros LJ, Curry JL, Tetzlaff MT, Torres-Cabala CA, Nagarajan P, Ravandi-Kashani F, Duvic M. Pruritic arthropod bite-like papules in T-cell large granular lymphocytic leukaemia and chronic myelomonocytic leukaemia. Clinical and Experimental Dermatology 43(4):449-453, 2018. e-Pub 2018. PMID: 29423961.
69. Saenz-Ibarra B, Prieto VG, Torres-Cabala CA, Huen A, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Aung PP. Coccidioidomycosis Involving Lungs and Skin: A Mimicker of Metastatic Disease. American Journal of Dermatopathology 40(3):e41-e43, 2018. PMID: 28857979.
70. Tetzlaff MT, Nelson KC, Diab A, Staerkel GA, Nagarajan P, Torres-Cabala CA, Chasen BA, Wargo JA, Prieto VG, Amaria RN, Curry JL. Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients. Journal for ImmunoTherapy of Cancer 6(1):14, 2018. PMID: 29433571.
71. Jour G, Aung PP, Merrill ED, Curry JL, Tetzlaff MT, Nagarajan P, Ivan D, Prieto VG, Duvic M, Miranda RN, Torres-Cabala CA. Differential expression of CCR4 in primary cutaneous gamma/delta (γδ) T cell lymphomas and mycosis fungoides: Significance for diagnosis and therapy. Journal of Dermatologic Sciences 89(1):88-91, 2018. e-Pub 2017. PMID: 29030090.
72. Boddu P, Chen PL, Nagarajan P, Prieto VG, Won A, Chambers M, Kornblau S. Necrotizing fungal gingivitis in a patient with Acute Myelogenous Leukemia: visible yet obscure. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology 30(1):50-54, 2018. PMID: 29404266.
73. Loghavi S, Curry JL, Garcia-Manero G, Patel KP, Xu J, Khoury JD, Torres-Cabala CA, Nagarajan P, Aung PP, Gibson BR, Goodwin BP, Kelly BC, Korivi BR, Medeiros LJ, Prieto VG, Kantarjian HM, Bueso-Ramos CE, Tetzlaff MT. Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: expanding the spectrum of skin lesions in chronic myelomonocytic leukemia. Journal of Cutaneous Pathology 44(12):1075-1079, 2017. PMID: 28885734.
74. Tetzlaff MT, Jazaeri AA, Torres-Cabala CA, Korivi BR, Landon GA, Nagarajan P, Choksi A, Chen L, Uemura M, Aung PP, Diab A, Sharma P, Davies MA, Amaria R, Prieto VG, Curry JL. Erythema nodosum-like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapy-Report of 2 patients. Journal of Cutaneous Pathology 44(12):1080-1086, 2017. e-Pub 2017. PMID: 28901560.
75. Lewis DJ, Dao H, Nagarajan P, Duvic M. Primary cutaneous anaplastic large-cell lymphoma: Complete remission for 13 years after denileukin diftitox. JAAD Case Reports 3(6):501-504, 2017. PMID: 29296637.
76. Ramani N, Aung PP, Hwu WJ, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Prieto VG, Torres-Cabala CA. Aberrant Expression of FLI-1 in Melanoma. Journal of Cutaneous Pathology 44(9):790-793, 2017. PMID: 28605142.
77. D'souza NM, Nguyen HD, Smith SV, Nagarajan P, Diab A, Allen RC, Gombos DS, Lee AG. Metastatic Melanoma of the Optic Nerve Sheath. Neuro-Ophthalmology 42(3):187-190, 2017. PMID: 29796055.
78. Shustef E, Torres-Cabala CA, Curry JL, Tetzlaff MT, Nagarajan P, Ivan D, Prieto VG, Aung PP. Intraepithelial Melanoma in the Stomach After Treatment With Immune Checkpoint Blockade Therapy. American Journal of Dermatopathology 39(8):e116-e118, 2017. PMID: 28248716.
79. Lewis DJ, Turkeltaub AE, Dai J, Nagarajan P, Rieger KE, Nunez CA, Kim YH, Duvic M. An adolescent with granulomatous mycosis fungoides infiltrating skeletal muscle successfully treated with oral prednisone. JAAD Case Reports 3(4):276-279, 2017. PMID: 28653029.
80. Konopinski J, Prieto VG, Ivan D, Nagarajan P, Tetzlaff MT, Curry JL, Torres-Cabala CA, Fuller GN, Aung PP. Isolated Ectopic Cutaneous Atypical Meningioma of the Scalp: Another Mimicker of Primary Adnexal Tumor. American Journal of Dermatopathology 39(7):545-547, 2017. PMID: 28178009.
81. Yanik EL, Pfeiffer RM, Freedman DM, Weinstock MA, Cahoon EK, Arron ST, Chaloux M, Connolly MK, Nagarajan P, Engels EA. Spectrum of Immune-Related Conditions Associated with Risk of Keratinocyte Cancers among Elderly Adults in the United States. Cancer Epidemiology, Biomarkers and Prevention 26(7):998-1007, 2017. PMID: 28377416.
82. Aung PP, Rady PL, Nagarajan P, Ivan D, Tetzlaff MT, Curry JL, Tyring SK, Prieto VG, Torres-Cabala CA. Detection of Merkel Cell Polyoma Virus and Beta Human Papillomavirus in Multiple Eccrine Poromas in a Patient With Acute Leukemia Treated With Stem Cell Transplant. American Journal of Dermatopathology 39(6):489-491, 2017. PMID: 27655121.
83. Valero-Torres A, Prieto VG, Nagarajan P, Torres-Cabala CA, Tetzlaff MT, Curry JL, Ivan D, Aung PP. Metastatic Melanoma With Papillary Features: A Mimic and Possible Diagnostic Pitfall. American Journal of Dermatopathology 39(6):468-470, 2017. PMID: 28525424.
84. Nagarajan P, Curry JL, Ning J, Piao J, Torres-Cabala CA, Aung PP, Ivan D, Ross, MI, Levenback C, Frumovitz M, Gershenwald JE, Davis MA, Malpica A, Prieto VG, Tetzlaff MT. Tumor thickness and mitotic rate robustly predict melanoma-specific survival in patients with primary vulvar melanoma: A retrospective review of 100 cases. Clinical Cancer Research 23(8):2093-2104, 2017. PMID: 27864417.
85. Yilmaz AS, Ozer HG, Gillespie JL, Allain DC, Bernhardt MN, Furlan KC, Castro LT, Peters SB, Nagarajan P, Kang SY, Iwenofu OH, Olencki T, Teknos TN, Toland AE. Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors. Cancer 123(7):1184-1193, 2017. PMID: 27906449.
86. Curry JL, Tetzlaff MT, Nagarajan P, Drucker C, Diab A, Hymes SR, Duvic M, Hwu WJ, Wargo JA, Torres-Cabala CA, Rapini RP, Prieto VG. Diverse types of dermatologic toxicities from immune checkpoint blockade therapy. Journal of Cutaneous Pathology 44(2):158-176, 2017. e-Pub 2016. PMID: 27859479.
87. Merrill ED, Agbay R, Miranda RN, Aung PP, Tetzlaff MT, Young KH, Curry JL, Nagarajan P, Ivan D, Prieto VG, Medeiros LJ, Duvic M, Torres-Cabala CA.. Primary cutaneous T-cell lymphomas showing gamma-delta (γδ) phenotype and predominantly epidermotropic pattern are clinicopathologically distinct from classic primary cutaneous γδ T-cell lymphomas. American Journal of Surgical Pathology 41(2):204-215, 2017. e-Pub 2016. PMID: 27879514.
88. Tetzlaff MT, Nagarajan P, Chon S, Huen A, Diab A, Omar P, Aung PP, Torres-Cabala CA, Mays SR, Prieto VG, Curry JL. Lichenoid Dermatologic Toxicity from Immune Checkpoint Blockade Therapy: A Detailed Examination of the Clinicopathologic Features. American Journal of Dermatopathology 39(2):121-129, 2017. PMID: 28134729.
89. Siroy AE, Aung PP, Torres-Cabala CA, Tetzlaff MT, Nagarajan P, Milton DR, Curry JL, Ivan D, Prieto VG. Clinical Significance of BRAF V600E Mutational Status in Capsular Nevi of Sentinel Lymph Nodes in Patients with Primary Cutaneous Melanoma. Human Pathology 59:48-54, 2017. e-Pub 2016. PMID: 27666765.
90. Jain P, Nagarajan P, Prayag P, Benton CB, Kadia T, Groisberg R, Kontoyiannis DP, Mulanovich VE, Pemmaraju N. Mixed angioinvasive exserohilum and scedosporium infection in a patient with AML. American Journal of Hematology 92(1):119-120, 2017. PMID: 27341684.
91. Al-Rohil RN, Torres-Cabala CA, Patel A, Tetzlaff MT, Ivan D, Nagarajan P, Curry JL, Miranda RN, Duvic M, Prieto VG, Aung PP. Loss of CD30 expression after treatment with Brentuximab Vedotin in a patient with Anaplastic Large Cell Lymphoma: a novel finding. Journal of Cutaneous Pathology 43(12):1161-1166, 2016. e-Pub 2016. PMID: 27531242.
92. Honarpisheh HH, Curry JL, Richards K, Nagarajan P, Aung PP, Torres-Cabala CA, Ivan D, Drucker CR, Cartun R, Prieto VG, Tetzlaff MT. Cutaneous histoplasmosis with prominent parasitization of epidermal keratinocytes: report of a case. Journal of Cutaneous Pathology 43(12):1155-1160, 2016. e-Pub 2016. PMID: 27516534.
93. Feldmeyer L, Hudgens CW, Lyons GR, Nagarajan P, Aung PP, Curry JL, Torres Cabala CA, Mino B, Rodriguez-Canales J, Reuben A, Chen PL, Ko JS, Billings SD, Bassett RL, Wistuba II, Cooper ZA, Prieto VG, Wargo JA, Tetzlaff MT. Density, distribution, and composition of immune infiltrates correlate with survival in Merkel cell carcinoma. Clinical Cancer Research 22(22):5553-5563, 2016. PMID: 27166398.
94. Jour G, Glitza IC, Ellis RM, Torres-Cabala CA, Tetzlaff MT, Li JY, Nagarajan P, Huen A, Aung PP, Ivan D, Drucker CR, Prieto VG, Rapini RP, Patel A, Curry JL. Autoimmune Dermatologic Toxicities from Immune Checkpoint Blockade with anti-PD-1 Antibody Therapy: A Report on Bullous Skin Eruptions. Journal of Cutaneous Pathology 43(8):688-96, 2016. e-Pub 2016. PMID: 27086658.
95. Feldmeyer L, Tetzlaff M, Fox P, Nagarajan P, Curry J, Ivan D, Torres Cabala CA, Prieto VG, Aung PP. Prognostic significance of lymphovascular invasion detected by double immunostaining for D2-40 and MITF in patients with cutaneous melanoma. American Journal of Dermatopathology 38(7):484-91, 2016. PMID: 26675354.
96. Gillespie J, Skeeles LE, Allain DC, Kent MN, Peters SB, Nagarajan P, Yu L, Teknos TN, Olencki T, Toland AE. MicroRNA expression profiling in metastatic cutaneous squamous cell carcinoma. Journal of European Academy of Dermatology and Venereology 30(6):1043-5, 2016. PMID: 25764000.
97. Nagarajan P, Bartholomew TS, Allen CM, Peters SB. Hair Follicle Nevus with features of Comedo Nevus: an expanding spectrum. American Journal of Dermatopathology 38(6):e81-e86, 2016. PMID: 26844616.
98. Schlichte MJ, Talpur R, Venkatarajan S, Curry JL, Nagarajan P, Duvic M. Verrucous Presentation in Patients with Mycosis Fungoides. International Journal of Dermatology 55(3):e126-9, 2016. PMID: 26519087.
99. Al-Rohil RN, Curry JL, Torres-Cabala CA, Nagarajan P, Ivan D, Aung PP, Ray GF, Bassett RL, Prieto VG, Tetzlaff MT. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors. Human Pathology 53:73-81, 2016. e-Pub 2016. PMID: 27004944.
100. Feldmeyer L, Prieto VG, Ivan D, Nagarajan P, Tetzlaff MT, Curry JL, Bell D, Moon BS, Torres-Cabala CA, Aung PP. Role of Radiotherapy in Aggressive Digital Papillary Adenocarcinoma. Annals of Clinical & Laboratory Science 46(2):222-4, 2016. PMID: 27098633.
101. Lee GL, Gru AA, Wong HK, Nagarajan P. Granulomatous Syphilis: a pattern to remember. Case Report and Review of Literature. (**Mentorship role**). Clinical Microbiology-Open Access 4:184, 2015.
102. Nagarajan P, Tober KL, Riggenbach JA, Kusewitt DF, Lehman AM, Sielecki T, Pruitt J, Satoskar AR, Oberyszyn TM. MIF Antagonist (CPSI-1306) Protects against UVB-Induced Squamous Cell Carcinoma. Molecular Cancer Research 12(9):1292-302, 2014. PMID: 24850900.
103. Craig ES, Nagarajan P, Lee ES, Lazova R, Terner J, Narayan D. The perichondrium in auricular melanomas: implications for surgical management. Otolaryngology-Head and Neck Surgery 148(3):431-5, 2013. PMID: 23223521.
104. Nagarajan P, Huttner A. A 77-year-old man with sudden onset of left hand weakness and hematuria. Neuropathology 33(1):102-7, 2013. PMID: 22672570.
105. Chin SS, Romano RA, Nagarajan P, Sinha S, Garrett-Sinha LA. Aberrant epidermal differentiation and disrupted deltaNp63/Notch regulatory axis in Ets1 transgenic mice. Biology Open 2(12):1336-45, 2013. PMID: 24337118.
106. Nagarajan P, Cai G, Padda MS, Selbst M, Kowalski D, Proctor DD, Chhieng D, Aslanian HR, Harigopal M. Littoral cell angioma of the spleen diagnosed by endoscopic ultrasound-guided fine-needle aspiration biopsy. Diagnostic Cytopathology 39(5):318-22, 2011. PMID: 21488173.
107. Gunturu KS, Nagarajan P, McPhedran P, Goodman TR, Hodsdon ME, Strout MP. Ayurvedic herbal medicine and lead poisoning. Journal of Hematology and Oncology 4:51, 2011. PMID: 22185092.
108. Nagarajan P, Chin SS, Wang D, Liu S, Sinha S, Garrett-Sinha LA. Ets1 blocks terminal differentiation of keratinocytes and induces expression of matrix metalloproteases and innate immune mediators. Journal of Cell Science 123(Pt 20):3566-75, 2010. PMID: 20930145.
109. Marella NV, Seifert B, Nagarajan P, Sinha S, Berezney R. Chromosomal rearrangements during human epidermal keratinocyte differentiation. Journal of Cellular Physiology 221(1):139-46, 2009. PMID: 19626667.
110. Nagarajan P, Parikh N, Garrett-Sinha LA, Sinha S. Ets1 induces dysplastic changes when expressed in terminally-differentiating squamous epidermal cells. PLoS One 4(1):e4179, 2009. PMID: 19142229.
111. Parikh N, Nagarajan P, Sei-ichi M, Sinha S, Garrett-Sinha LA. Isolation and characterization of an immortalized oral keratinocyte cell line of mouse origin. Archives of Oral Biology 53(11):1091-100, 2008. PMID: 18721915.
112. Nagarajan P, Sinha S. Development of an inducible gene expression system for primary murine keratinocytes. Journal of Dermatological Science 49(1):73-84, 2008. PMID: 17964120.
113. Damodaran S, Wood TD, Nagarajan P, Rabin RA. Evaluating peptide mass fingerprinting-based protein identification. Genomics Proteomics Bioinformatics 5(3-4):152-7, 2007. PMID: 18267296.

Invited Articles

1. Mejbel HA, Vu KAT, Nagarajan P. Dermatopathology in Endocrine Disease (**Mentoring role**). Diagnostic Histopathology 26(5):224-232, 2020.
2. Nagarajan P, Asgari MM, Green AC, Guhan SM, Arron ST, Proby CM, Rollison DE, Harwood CA, Toland AE. Keratinocyte Carcinomas: Current concepts and future research priorities. Clinical Cancer Research 25(8):2379-2391, 2019. e-Pub 2018. PMID: 30523023.
3. Nagarajan P. Ceruminous Neoplasms of the Ear. Head and Neck Pathology 12(3):350-361, 2018. e-Pub 2018. PMID: 30069843.
4. Tetzlaff MT, Nagarajan P. Update on Merkel cell carcinoma. Head Neck Pathol 12(1):31-43, 2018. PMID: 29556962.
5. Aung PP*, Nagarajan P*, Prieto VG (* Equal contributors). Regression in primary cutaneous melanoma: etiopathogensis and clinical significance. Laboratory Investigation 97:657-668, 2017. PMID: 28240749.
6. Nagarajan P, Tetzlaff MT, Curry JL, Prieto VG. Use of new techniques in addition to IHC applied to the diagnosis of melanocytic lesions, with emphasis on CGH, FISH, and Mass Spectrometry. Actas Dermo-Sifiliográficas 108(1):17-30, 2017. PMID: 27344067.
7. Nagarajan P, Ivan D. Cutaneous Squamous Cell Carcinomas: Focus on high-risk features and molecular alterations. Global Dermatology 3(4):359-365, 2016. e-Pub 2016.
8. Nagarajan P, Romano RA, Sinha S. Transcriptional control of the differentiation program of interfollicular epidermal keratinocytes. Critical Reviews in Eukaryotic Gene Expression 49(1):73-84, 2008. PMID: 18197786.

Manuals, Teaching Aids, Other Teaching Publications

1. Nagarajan P. Pigmented lesions. Malignant neoplasms of vulva. Pathology Outlines, 2015.
2. Nagarajan P. Melanoma. Malignant neoplasms of vulva. Pathology Outlines, 2015.

Editorials

1. Nagarajan P, Tober KL, Satoskar AR, Oberyszyn TM. MIF antagonist (CPSI-1306) protects against UVB-induced squamous cell carcinoma, 2015.

Abstracts

1. Ali Y, Meis JM, Thomas V, Wang WL, Torres-Cabala CA, Hymes S, Alousi AM, Moon BS, Roland CL, Wong MK, Conley AP, Tetzlaff MT, Curry JL, Ivan D, Aung PP, Prieto VG, Nagarajan P. Chronic Sclerodermoid Dermatosis-Associated Aggressive Cutaneous Squamous Cell Carcinomas: Report of 3 Cases (**Mentoring role**). The 57th Annual Meeting of The American Society of Dermatopathology, 2020.
2. Roy M, Lawrence TJ, Middleton LP, Nagarajan P. Cytokeratin-7 Negative Mammary Paget Disease, a Rare Entity and Diagnostic Dilemma (**Mentoring role**). The 57th Annual Meeting of The American Society of Dermatopathology, 2020.
3. Nagarajan P, Westerman ME, Bassett Jr R, Tamboli P, Li R, Jones A, Haydu LE, Prieto VG, Curry JL,Torres-Cabala CA,Ivan D, Aung PP, Gershenwald JE, Davies MA, Tetzlaff MT, Pettaway C. Prognostic model for T-categorization of primary male genitourinary melanoma (MGUM). The 57th Annual Meeting of The American Society of Dermatopathology, 2020.
4. McNally M, Vangipuram R, Messer A, Jahan-Tigh R, Nagarajan P, Hebertion M. Pembrolizumab associated Paraneoplastic Pemphigus. Texas Dermatological Society 2020 Annual Fall Meeting, 2020.
5. Cho WC, Prieto VG, Gruschkus S, Bassett Jr RL, Torres-Cabala CA, Tetzlaff MT, Curry JL, Aung PP, Ivan DS, Davies MA, Nagarajan P. Primary Cutaneous Melanoma of the Umbilicus: A retrospective Study of 18 Patients (**Mentoring role**). 109th Annual Meeting of The United States and Canadian Academy of Pathology, 2020. e-Pub 2020.
6. Aung PP, Namikawa K, Milton DR, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Torres-Cabala CA, Prieto VG. Correlation between Metastatic Tumor Burden in Sentinel and Non-Sentinel Lymph Nodes and Prognostic Significance of Tumor Burden in Sentinel Nodes in 336 Patients with Cutaneous Melanoma: A Single-Institution Retrospective Study. 109th Annual Meeting of The United States and Canadian Academy of Pathology, 2020. e-Pub 2020.
7. Pradhan D, Milton DR, Vasudevaraja V, Tetzlaff MT, Nagarajan P, Curry JL, Ivan D, Long L, Ding Y, Ezhilarasan R, Sulman E, Hwu WJ, Prieto VG, Torres-Cabala CA, Aung PP. Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral Melanoma. 109th Annual Meeting of The United States and Canadian Academy of Pathology, 2020. e-Pub 2020.
8. Ronen S, Keiser E, Al-Rohil RN, Jour G, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Torres-Cabala CA, Prieto VG, Aing PP. Discordance in Diagnosis of Melanocytic Lesions and its Impact on Management: A Melanoma Referral Center Experience with 1718 Cases. 109th Annual Meeting of The United States and Canadian Academy of Pathology, 2020. e-Pub 2020.
9. Keiser E, Ronen S, Al-Rohil RN, Jour G, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Torres-Cabala CA, Prieto VG, Aung PP. Factors Associated with Patient Outcomes After Diagnosis with Invasive Melanoma; an 8-year Retrospective Study of AJCC Staging and Clinical Parameters. 109th Annual Meeting of The United States and Canadian Academy of Pathology, 2020. e-Pub 2020.
10. Keiser E, Ronen S, Ivan D, Torres-Cabala CA, Tetzlaff MT, Curry JL, Aung PP, Prieto VG, Nagarajan P. Squamoid Eccrine Ductal Carcinoma: Elucidating Clinicopathologic Features of Prognostic Significance (**Mentoring role**). 109th Annual Meeting of The United States and Canadian Academy of Pathology, 2020. e-Pub 2020.
11. Marques-Piubelli ML, Tetzlaff MT, Muhlbauer A, Wang J, Nelson K, Nagarajan P, Aung PP, Torres-Cabala CA, Pacha O, Prieto VG, Subramanya S, Wistuba II, Curry JL. Differentially Expressed Genes in Bullous Pemphigoid Immune-Related Adverse Event (BP-irAE) from Immune Checkpoint Inhibitor Therapy: Implications in the Immunopathogenic Mechanisms Driving BP-irAE Compared to De Novo BP Control. 109th Annual Meeting of The United States and Canadian Academy of Pathology, 2020. e-Pub 2020.
12. Mejbel HA, Mori T, Torres-Cabala CA, Milton DR, Muto Y, Nakama K, Yamazaki N, Nagarajan P, Tetzlaff MT, Ivan D, Curry JL, Hwu , Prieto VG, Namikawa K, Aung PP. Comparative Study of Acral Lentiginous Melanoma in Patients from USA and Japan. 109th Annual Meeting of The United States and Canadian Academy of Pathology, 2020. e-Pub 2020.
13. Ramani N, Gu J, Aung PP, Sfamenos SM, Sdringola-Maranga C, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Diab A, Hwu WJ, Prieto VG, Torres-Cabala CA. TERT Amplification is Involved in Acral Lentiginous Melanoma Progression to Metastasis. 109th Annual Meeting of The United States and Canadian Academy of Pathology, 2020. e-Pub 2020.

Book Chapters

1. Torres-Cabala CA, Tetzlaff MT, Nagarajan P, Ivan D, Curry JL, Aung PP, Prieto VG. Skin: Keratinocytic tumors. In: Oncological Surgical Pathology. 1. Springer: New York, 3-227, 2020.
2. Nagarajan P, Euscher ED, Tamboli P, Prieto VG. Malignant Neoplasms of the Vulva and the Penis. In: Gynaecologic and Urologic Pathology. Similarities, Differences and Challenges. 1. Cambridge University Press: Cambridge, 2019.
3. Nagarajan P, Euscher ED, Tamboli P, Prieto VG. Miscellaneous lesions of the vulva and penis. In: Gynaecologic and Urologic Pathology. Similarities, Differences and Challenges. 1. Cambridge University Press: Cambridge, 2019.
4. Coggshall K, Brooks III L, Nagarajan P, Arron S. The Microbiome and its Contribution to Skin Cancer. In: Microbiome and Cancer. 1. Springer International Publishing AG: Cham (ZG) Switzerland, 2019.
5. Nagarajan P, Tetzlaff MT, Curry JL. Histopathology of Basal Cell Carcinoma and Its Variants. In: Basal Cell Carcinoma: Advances in Research and Treatment. 1. Springer Nature: United Kingdom, 2019.
6. Nagarajan P. Pseudolymphomas at sites of vaccination and in tattoos. In: Hematopathology of the Skin: Clinical & Pathological Approach. 1. Wolters Kluwer Health, 487-492, 2016.
7. Nagarajan P. Lymphoid proliferations in association with viral and bacterial infections. In: Hematopathology of the Skin: Clinical & Pathological Approach. 1. Wolters Kluwer Health, 497-502, 2016.
8. Nagarajan P, Prieto VG. Basal Cell Carcinoma of the Male External Genitalia. In: Rare Genitourinary Tumors. 1. Springer, 299-310, 2016.
9. Al-Rohil R, Nagarajan P, and Tetzlaff MT. Molecular Studies Informing the Diagnosis of Melanocytic Lesions. In: Applied Immunohistochemistry in the Evaluation of Skin Neoplasms. 1. Springer, 2016.
10. Curry JL, Ana M. Ciurea, Nagarajan P, Torres-Cabala CA. Dermatologic Toxicities to Melanoma Targeted Therapy. In: Genetics of Melanoma. 1. Springer: New York, 267-277, 2016.
11. Curry JL, Tetzlaff MT, Nagarajan P, and Torres-Cabala CA. Immunohistology of Melanocytic Lesions. In: Applied Immunohistochemistry in the Evaluation of Skin Neoplasms. 1. Springer International Publishing AG, 2016.

Letters to the Editor

1. Ravishankar S, Nagarajan P, Curry JL, Tetzlaff MT, Ivan D, Torres-Cabala CA, Aung PP, Prieto VG. Giemsa is the optimal counterstain for immunohistochemical detection of BRAF V600E mutation status in pigmented melanomas (**Mentoring role**). Journal of Cutaneous Pathology 43: 722-4, 2016.
2. Nagarajan P, Sloan BS. Isolated Cutaneous Leishmaniasis by Leishmania donovani in a Soldier Returning From Afghanistan. American Journal of Dermatopathology 37: 591-2, 2015.
3. Nagarajan P, Kenney B, Drost P, Galan A. An unusual case of Sporadic Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome. Cutis 95: E7-E9, 2015.